Selective Neural Nitric Oxide Synthase Inhibitors

Research output: Patent


Inhibitors of Neuronal Nitric Oxide Synthase NU 2001-057, 2003-083, 2005-128, 2008-172, 2008-179, 2009-024, 2009-164, 2010-008, 2010-075, 2011-053, 2012-112, 2012-146, 2013-020 Short description: A portfolio of neuronal nitric oxide synthase inhibitors for use in treating neurodegenerative disorders. #therapeutics #CNS Abstract: Northwestern researchers have created a diverse portfolio of neuronal nitric oxide synthase (nNOS) inhibitors. These inhibitors are potent, selective and able to permeate the blood-brain barrier. These small molecules include enhanced chemical compositions, such as those created by heteroaromatic selection, aminopyridine dimers, chiral pyrrolidine cores, azole rings that facilitate heme binding, intramolecular hydrogen bonding, and thiophene-2-carboximidamide-based compounds. The methods for synthesis as well as the small molecules are patented or have patent applications under review. Specific information on the individual compositions is available on request. Applications: o Therapeutic for neurological disorders, such as: o Stroke o Schizophrenia o Migraine Headaches o Cerebral Ischemia o Long-Term Depression o Therapy for neurodegenerative disorders, such as Huntington's disease, Parkinson's disease and Alzheimer's disease o Potential for use in other disorders where nNOS is a therapeutic target Advantages: o Variety of chemical compositions o Potent o Selective o Bioavailable o Permeate the blood-brain barrier o Selectivity results in reduced side effects compared to general NOS inhibitors Inventors: Richard B. Silverman* Hui Huang Henry Qingwei Zhang Erik Erdal Jose Antonio Gomez Vidal Jung-Mi Hah Mark Flinspach Haitao Mark Ji Huiying Li Thomas L. Poulos Graham R. Lawton Fengtian Xue James M Kraus He Huang Qing Jing IP Status: Issued U.S. Patents: 7,470,815; 8,158,658; 7,470,790; 7,994,326; 7,994,326; 7,994,326; 8,299,100; 8,278,084; 8,389,731; 8,618,143; 8,697,879; 8,557,552; 8,735,606; 8,735,606. Additional U.S. patent applications have been filed. International patent applications have also been filed.
Original languageEnglish
Patent number7470815
StatePublished - Dec 30 2008


Dive into the research topics of 'Selective Neural Nitric Oxide Synthase Inhibitors'. Together they form a unique fingerprint.

Cite this